Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$939K Sell
39,006
-2,057
-5% -$53.8K 0.06% 205
2026
Q1
$1.15M Buy
41,063
+1,717
+4% +$45.7K 0.08% 166
2025
Q4
$980K Buy
39,346
+2,804
+8% +$70.7K 0.08% 164
2025
Q3
$931K Sell
36,542
-33,188
-48% -$819K 0.08% 164
2025
Q2
$1.69M Buy
69,730
+14,264
+26% +$333K 0.17% 89
2025
Q1
$1.41M Buy
55,466
+1,924
+4% +$50.3K 0.16% 88
2024
Q4
$1.42M Buy
53,542
+4,140
+8% +$112K 0.16% 89
2024
Q3
$1.43M Buy
49,402
+2,240
+5% +$65.3K 0.14% 116
2024
Q2
$1.32M Buy
47,162
+6,448
+16% +$178K 0.14% 120
2024
Q1
$1.13M Buy
40,714
+5,512
+16% +$153K 0.13% 145
2023
Q4
$1.01M Buy
35,202
+365
+1% +$11K 0.13% 142
2023
Q3
$1.16M Sell
34,837
-16,220
-32% -$574K 0.17% 111
2023
Q2
$1.87M Sell
51,057
-625
-1% -$24.3K 0.31% 63
2023
Q1
$2.11M Sell
51,682
-1,195
-2% -$51.6K 0.51% 46
2022
Q4
$2.71M Buy
52,877
+8,203
+18% +$393K 0.72% 32
2022
Q3
$1.96M Sell
44,674
-4,452
-9% -$216K 0.59% 37
2022
Q2
$2.58M Buy
49,126
+9,379
+24% +$478K 0.75% 28
2022
Q1
$2.06M Sell
39,747
-166
-0.4% -$8.61K 0.6% 36
2021
Q4
$2.36M Buy
39,913
+11,293
+39% +$560K 0.48% 55
2021
Q3
$1.23M Buy
28,620
+2,255
+9% +$99.9K 0.27% 86
2021
Q2
$1.03M Buy
26,365
+7,721
+41% +$300K 0.21% 89
2021
Q1
$677K Buy
18,644
+3,311
+22% +$118K 0.15% 104
2020
Q4
$565K Buy
15,333
+6,344
+71% +$233K 0.15% 78
2020
Q3
$314K Buy
+8,989
New +$315K 0.13% 80

Other funds holding PFE

Advisor OS's PFE Position: Q2 2026 in Review

Advisor OS reduced its Pfizer (PFE) stake by 5% in Q2 2026, selling an estimated $53.8K and leaving 39,006 shares worth $939K. The position accounts for 0.06% of the portfolio, ranked #205.

Advisor OS first reported a position in PFE in Q3 2020 and has held it in 24 quarters since. The position peaked at $2.71M in Q4 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Advisor OS held 39,006 shares of Pfizer worth $939K as of Q2 2026.
  • Advisor OS sold 2,057 Pfizer shares in Q2 2026, an estimated $53.8K.
  • Pfizer made up 0.06% of Advisor OS's portfolio in Q2 2026, its #205 holding.
  • Advisor OS first reported a position in Pfizer in Q3 2020 and has held it in 24 quarters since.
  • Advisor OS's Pfizer position peaked at $2.71M in Q4 2022.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Advisor OS's 13F filing for Q2 2026, filed 5 Aug 2026.